METPRO: Evaluating prognostic value of c-Met protein overexpression and concurrent biomarker presence

被引：0
|
作者：
Le, X. [1 ]
Aggarwal, C. [2 ]
Simmons, A. [3 ]
Crawford, S. A. [3 ]
Ng, S. [3 ]
Chen, C. [3 ]
Karve, S. [3 ]
Stein, S. [3 ]
Woll, K. [3 ]
Ansell, P. J. [3 ]
Mistry, A. [3 ]
Bryant, D. [4 ]
Wistuba, I. I. [1 ]
机构：
[1] MD Anderson, Thorac Head & Neck, Houston, TX USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Penn Ctr Canc Care Innovat, Philadelphia, PA USA
[3] AbbVie Inc, US Med Affairs, N Chicago, IL USA
[4] Caris Life Sci, Oncol, Dallas, TX USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1303P
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [1] Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
    Kim, Jung Han
    Kim, Hyeong Su
    Kim, Bum Jun
    Lee, Jin
    Jang, Hyun Joo
    ONCOTARGET, 2017, 8 (42) : 73098 - 73104
  • [2] Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
    M Miyamoto
    H Ojima
    M Iwasaki
    H Shimizu
    A Kokubu
    N Hiraoka
    T Kosuge
    D Yoshikawa
    T Kono
    H Furukawa
    T Shibata
    British Journal of Cancer, 2011, 105 : 131 - 138
  • [3] Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
    Miyamoto, M.
    Ojima, H.
    Iwasaki, M.
    Shimizu, H.
    Kokubu, A.
    Hiraoka, N.
    Kosuge, T.
    Yoshikawa, D.
    Kono, T.
    Furukawa, H.
    Shibata, T.
    BRITISH JOURNAL OF CANCER, 2011, 105 (01) : 131 - 138
  • [4] Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
    Kim, Jung Han
    Kim, Hyeong Su
    Kim, Bum Jun
    Jang, Hyun Joo
    Lee, Jin
    ONCOTARGET, 2017, 8 (52) : 90351 - 90357
  • [5] Prognostic Value of C-met Expression in Cholangiocarcinoma
    Mao, Zhi-Yuan
    Zhu, Guang-Qing
    Ren, Li
    Guo, Xiao-Chuan
    Su, Dan
    Bai, Li
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (02) : 227 - 233
  • [6] c-Met is a new prognostic biomarker in glioblastoma patients
    Petterson, Stine A.
    Hermansen, Simon K.
    Dahlrot, Rikke H.
    Hansen, Steinbjorn
    Kristensen, Bjarne W.
    APMIS, 2014, 122 : 36 - 36
  • [7] C-MET IS A NEW PROGNOSTIC BIOMARKER IN GLIOBLASTOMA PATIENTS
    Petterson, Stine Asferg
    Hermansen, Simon Kjaer
    Dahlrot, Rikke Hedegaard
    Hansen, Steinbjorn
    Kristensen, Bjarne Winther
    NEURO-ONCOLOGY, 2013, 15 : 156 - 156
  • [8] Prevalence of c-Met overexpression (c-Met plus ) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
    Motwani, M.
    Panchabhai, S.
    Bar, J.
    Girard, N.
    Bradbury, P.
    Lu, S.
    Jin, J.
    Hotson, A.
    Maag, D.
    Planchard, D.
    Camidge, D. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1169 - S1170
  • [9] Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
    Zhao, Xixi
    Qu, Jingkun
    Hui, Yuxin
    Zhang, Hong
    Sun, Yuchen
    Liu, Xu
    Zhao, Xiaoyao
    Zhao, Zitong
    Yang, Qian
    Wang, Feidi
    Zhang, Shuqun
    ONCOTARGET, 2017, 8 (34) : 56758 - 56767
  • [10] The Prognostic Significance of C-Met and EGFR Overexpression in Gastric Carcinomas
    Paliga, A.
    Marginean, H.
    Purgina, B.
    Tessier, B.
    Jonker, D.
    Marginean, E. C.
    MODERN PATHOLOGY, 2014, 27 : 196A - 196A
12345